Overview

Epothilone in Recurrent Glioblastoma Patients

Status:
Completed

Trial end date:
2008-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this single arm phase II study is to evaluate safety and efficacy of ZK 219477 in the treatment of temozolomide pre-treated, recurrent GBM patients.

Phase:

Phase 2

Details

Lead Sponsor:

Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

Treatments:

Epothilones
Sagopilone